Vir Biotechnology to Present at 40th Annual Cowen Healthcare Conference
February 24, 2020 20:47 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious...
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of 2019-nCoV, Newly Named as SARS-CoV-2
February 12, 2020 08:30 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious...
Vir Biotechnology applying multiple platforms to address public health risk from Wuhan coronavirus
January 22, 2020 17:45 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious...
Vir Biotechnology to Provide Pipeline Update at 38th Annual J.P. Morgan Healthcare Conference
January 13, 2020 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies...
Vir Biotechnology to Present at 38th Annual J.P. Morgan Healthcare Conference
January 07, 2020 17:09 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies...
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
November 19, 2019 16:15 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies...
Vir Biotechnology Announces Pricing of Initial Public Offering
October 10, 2019 19:41 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies...